Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 1,042 Shares of Stock

Posted by George Bondi on Aug 12th, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 1,042 shares of Omada Health stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the sale, the chief accounting officer directly owned 15,441 shares in the company, valued at approximately $386,025. This trade represents a 6.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Craig Gracey also recently made the following trade(s):

On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The shares were sold at an average price of $23.00, for a total value of $14,651.00.
On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total value of $8,910.00.
On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total value of $39,597.83.
On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.
On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Down 0.7%

Omada Health stock traded down $0.17 on Wednesday, hitting $23.84. The company’s stock had a trading volume of 1,552,408 shares, compared to its average volume of 1,274,695. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The firm has a market cap of $1.46 billion, a P/E ratio of 476.80 and a beta of 1.73. The company has a fifty day moving average price of $20.61 and a 200-day moving average price of $16.32.

Omada Health (NASDAQ:OMDA – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The company had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. Analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Trading of Omada Health

Several large investors have recently made changes to their positions in the business. Perceptive Advisors LLC bought a new position in shares of Omada Health in the second quarter valued at about $44,402,000. BlackRock Inc. acquired a new stake in Omada Health in the 2nd quarter valued at about $48,775,000. Millennium Management LLC increased its position in Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after acquiring an additional 2,096,705 shares in the last quarter. Jefferies Financial Group Inc. bought a new position in shares of Omada Health in the fourth quarter worth about $16,948,000. Finally, SG Americas Securities LLC acquired a new position in shares of Omada Health during the first quarter worth approximately $10,401,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on OMDA shares. Barclays raised their target price on Omada Health from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Robert W. Baird increased their price objective on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday. Citigroup reissued an “outperform” rating on shares of Omada Health in a report on Monday, July 20th. Finally, BMO Capital Markets restated an “outperform” rating and issued a $24.00 target price on shares of Omada Health in a research note on Friday, August 7th. Eleven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average price target of $25.75.

Check Out Our Latest Report on Omada Health

Omada Health News Summary

Here are the key news stories impacting Omada Health this week:

Positive Sentiment: Omada’s second-quarter results provided further evidence that revenue growth is translating into profitability. The company reported earnings of $0.08 per share versus a consensus loss of $0.02 and revenue of approximately $87.8 million, well above the $80.9 million analyst estimate. The results support the bullish case for Omada’s digital chronic-care platform and improving financial execution. Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Positive Sentiment: Robert W. Baird raised its price target on OMDA from $15 to $25, reflecting improved expectations following the earnings performance. However, the firm maintained a neutral rating, indicating that much of the near-term upside may already be reflected in the stock price. Benzinga analyst update
Neutral Sentiment: Analyst sentiment remains broadly favorable, with a reported consensus rating of “Moderate Buy” and an average price target of $25.67. Recent targets range from $24 to $35, but the wide range highlights uncertainty around valuation and future growth.
Neutral Sentiment: Reported short interest was zero shares, offering no meaningful indication of short-selling pressure or potential short-covering demand.
Negative Sentiment: CEO Sean Duffy disclosed sales of 8,628 shares at an average price of $21.85 and 12,942 shares at $24.81. The transactions reduced his direct ownership by roughly 5% across the reported sales and may weigh on sentiment, although he still owns more than 411,000 shares.
Negative Sentiment: At roughly $24 per share, OMDA trades at a very high price-to-earnings ratio near 480, leaving the stock sensitive to disappointment in growth, margins or future earnings. Its recent performance has already placed it well above its 50-day and 200-day moving averages.

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Insider Buying and Selling by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.